Patents

US 11523984 B1: Compositions and methods of administering baclofen

Granted
2022-12-13
Filed
2021-11-12 application 17525298
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Injectable baclofen formulations and methods that are bioequivalent in terms of plasma baclofen exposure to oral dosage forms but with reduced exposure ratios of baclofen to the M1 metabolite.

Source: PVGPATDIS, file of 2026-04-10 (ipg221213.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
AMNEAL PHARMACEUTICALS LLC 33 patentsUS company or organizationBound Brook Junction, NJAMNEAL PHARMACEUTICALS LLC Federal lobbying client EXACT high confidence: identical full name and state
AMNEAL PHARMACEUTICALS, INC. SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationally
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Leonard O'MahonyMullingar, IE12PVGPATDIS, file of 2026-04-10
John DevaneDublin, IE16PVGPATDIS, file of 2026-04-10
Sharon HammGulf Pine, FL18PVGPATDIS, file of 2026-04-10
David PenakeAtlanta, GA21PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K9/0019PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P1/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2025-08-01Security interest Security interest
Patent security agreement
AMNEAL PHARMACEUTICALS LLC signed 2025-08-01
IMPAX LABORATORIES, LLC signed 2025-08-01
GEMINI LABORATORIES, LLC signed 2025-08-01
WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT WILMINGTON, DE72312/127PASDL, file of 2026-10-25
2023-11-17Security interest Security interest
Security interest
AMNEAL PHARMACEUTICALS LLC signed 2023-11-14JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT CHICAGO, IL65602/692PASDL, file of 2026-10-15
2022-06-10Security interest Security interest
Patent security agreement
AMNEAL PHARMACEUTICALS LLC signed 2022-06-02
IMPAX LABORATORIES, LLC signed 2022-06-02
GEMINI LABORATORIES LLC signed 2022-06-02
TRUIST BANK. AS ADMINISTRATIVE AGENT ATLANTA, GA60329/568PASDL, file of 2026-10-15
2022-02-10Assignment
Assignment of assignor's interest
SAOL INTERNATIONAL DEVELOPMENT LIMITED signed 2022-02-09
SAOL INTERNATIONAL LIMITED signed 2022-02-09
SAOL INTERNATIONAL RESEARCH LIMITED signed 2022-02-09
SAOL THERAPEUTICS RESEARCH LIMITED signed 2022-02-09
AMNEAL PHARMACEUTICALS LLC BRIDGEWATER, NJ58975/86ECORSEXC, file of 2026-09-25
2021-11-12Assignment
Assignment of assignor's interest
DEVANE, JOHN signed 2021-11-10
O'MAHONY, LEONARD signed 2021-11-10
HAMM, SHARON signed 2021-11-11
PENAKE, DAVID signed 2021-11-11
SAOL INTERNATIONAL DEVELOPMENT LTD. HAMILTON58099/962ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.